- How To
- Cigar Info
- Site Info
The U.S. Food and Drug Administration’s Tobacco Product Advisory Committee (TPSAC) has agreed that using Altria’s Copenhagen snuff is safer than smoking cigarettes, according to a report in Medpage Today.
Following a Feb. 6-7 hearing, the TPSAC voted 8-0, with one abstention, that Altria’s proposed modified-risk claim for Copenhagen snuff is scientifically accurate.
Altria had asked the FDA for permission to print the following text on the Copenhagen product label: “IF YOU SMOKE CONSIDER THIS: Switching completely to this product from cigarettes reduces risk of lung cancer.”
According to Altria, many smokers erroneously believe that smokeless tobacco products are as harmful or more harmful than cigarettes.
During its hearings, the TPSAC also discussed Swedish Match’s modified-risk tobacco product (MRTP) application for General snus. Several panel members reportedly hesitated to support the MRTP designation because they feared it could make snus more attractive to young people.
As of late last year, federal health officials had denied or delayed close to 20 MRTP applications from mostly smokeless products.
The FDA is not obliged to follow TPSAC recommendations, but it usually does.
Tagged with: Breaking News
Tag cloudsmokefree-policies smokeless Next-generation products op-ed teen-smoking-youth internet-technology opinion-surveys united states Cigars Regulation Premium Cigars business-general people Breaking News international florida uk labels-lights federal-national advertising-promos harm-reduction ingredients-menthol e-cigs fda lobbying business-tobacco society cross-border-crime Vapor alternate-reduced-risk industry-watch new-york cessation lawsuits altria-philip-morris Corporate tobacco-control tax nicotine top health-science elections-politics Featured secondhand-smoke canada